Literature DB >> 11237271

Myofiber injury and regeneration in a canine homologue of Duchenne muscular dystrophy.

M K Childers1, C S Okamura, D J Bogan, J R Bogan, M J Sullivan, J N Kornegay.   

Abstract

OBJECTIVE: To test the hypothesis that differential skeletal muscle involvement, previously observed in dogs with a homologue of Duchenne muscular dystrophy, correlates with the histochemical markers of myofiber injury and regeneration.
DESIGN: Evidence of injury (cellular penetration by Evans blue dye, immunoglobulin G expression, hematoxylin and eosin staining of necrotic figures), myofiber regeneration (fetal myosin heavy chain isoform expression), and morphologic indices in the cranial sartorius (CS), long digital extensor, and vastus lateralis muscles were examined in five dogs with dystrophy and five normal dogs.
RESULTS: Only the CS muscle, at 1 mo, demonstrated significant differences in injury when compared with age-matched controls. By 6 mo, the long digital extensor and vastus lateralis also suffered greater than normal injury. Only the dystrophic CS tissue expressed a notable increase in mean myofiber diameter when compared with other muscles at 6 mo. Normal CS muscles revealed a distinct population of small myofibers at this age.
CONCLUSION: The CS seems unique in its selective pathologic involvement. These differences may contribute to the marked regenerative response of this muscle in the dystrophic state. An improved understanding of mechanisms by which some dystrophin-deficient canine muscles remain spared from injury may provide clues to investigate and prevent the degenerative processes in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237271     DOI: 10.1097/00002060-200103000-00004

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  12 in total

1.  Adenoviral-mediated gene transfer into the canine brain in vivo.

Authors:  Marianela Candolfi; Kurt M Kroeger; G Elizabeth Pluhar; Josee Bergeron; Mariana Puntel; James F Curtin; Elizabeth A McNiel; Andrew B Freese; John R Ohlfest; Peter Moore; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

2.  In vivo canine muscle function assay.

Authors:  Martin K Childers; Robert W Grange; Joe N Kornegay
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

3.  A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.

Authors:  Jiahui Wang; Zheng Fan; Krista Vandenborne; Glenn Walter; Yael Shiloh-Malawsky; Hongyu An; Joe N Kornegay; Martin A Styner
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-01-09       Impact factor: 2.924

Review 4.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

5.  Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Authors:  Xuan Guan; David L Mack; Claudia M Moreno; Jennifer L Strande; Julie Mathieu; Yingai Shi; Chad D Markert; Zejing Wang; Guihua Liu; Michael W Lawlor; Emily C Moorefield; Tara N Jones; James A Fugate; Mark E Furth; Charles E Murry; Hannele Ruohola-Baker; Yuanyuan Zhang; Luis F Santana; Martin K Childers
Journal:  Stem Cell Res       Date:  2013-12-23       Impact factor: 2.020

6.  A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs.

Authors:  Yongping Yue; Arkasubhra Ghosh; Chun Long; Brian Bostick; Bruce F Smith; Joe N Kornegay; Dongsheng Duan
Journal:  Mol Ther       Date:  2008-09-30       Impact factor: 11.454

7.  Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy.

Authors:  Zheng Fan; Jiahui Wang; Mihye Ahn; Yael Shiloh-Malawsky; Nizar Chahin; Sandra Elmore; C Robert Bagnell; Kathy Wilber; Hongyu An; Weili Lin; Hongtu Zhu; Martin Styner; Joe N Kornegay
Journal:  Neuromuscul Disord       Date:  2013-10-30       Impact factor: 4.296

8.  Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs.

Authors:  Peter P Nghiem; Eric P Hoffman; Priya Mittal; Kristy J Brown; Scott J Schatzberg; Svetlana Ghimbovschi; Zuyi Wang; Joe N Kornegay
Journal:  Am J Pathol       Date:  2013-11       Impact factor: 4.307

9.  Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.

Authors:  Marianela Candolfi; G Elizabeth Pluhar; Kurt Kroeger; Mariana Puntel; James Curtin; Carlos Barcia; A K M Ghulam Muhammad; Weidong Xiong; Chunyan Liu; Sonali Mondkar; William Kuoy; Terry Kang; Elizabeth A McNeil; Andrew B Freese; John R Ohlfest; Peter Moore; Donna Palmer; Phillip Ng; John D Young; Pedro R Lowenstein; Maria G Castro
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

10.  Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.

Authors:  Martin K Childers; Janet R Bogan; Daniel J Bogan; Hansel Greiner; Melanie Holder; Robert W Grange; Joe N Kornegay
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.